Sandbox 9888: Difference between revisions

From Proteopedia
Jump to navigationJump to search
mNo edit summary
mNo edit summary
Line 34: Line 34:


<b>Ulcerative Colitis:</b>
<b>Ulcerative Colitis:</b>
Similar to Crohn’s disease, Ulcerative Colitis is a chronic inflammatory bowel disease that causes inflammation in the digestive tract, particularly the sigmoid colon of the large intestine and rectum <ref name="FDA"/>. Levels of TNF-α in stool samples is a technique used to assess the level of the disease in patients <ref name="FDA"/>. To promote intestinal healing, Remicade is a drug that can be prescribed to prevent the use of steroids in adults with moderate to severe symptoms <ref name="FDA"/>.  
Similar to Crohn’s disease, Ulcerative Colitis is a chronic inflammatory bowel disease that causes inflammation in the digestive tract, particularly the sigmoid colon of the large intestine and rectum <ref name="FDA"></ref>. Levels of TNF-α in stool samples is a technique used to assess the level of the disease in patients <ref name="FDA"></ref>. To promote intestinal healing, Remicade is a drug that can be prescribed to prevent the use of steroids in adults with moderate to severe symptoms <ref name="FDA"></ref>.  


<b>Ankylosing Spondylitis:</b>
<b>Ankylosing Spondylitis:</b>
Line 40: Line 40:


<b>Plaque Psoriasis:</b>
<b>Plaque Psoriasis:</b>
Plaque psoriasis is the most common form of the disease, appearing as raised, red patches covered with a off-white buildup of dead skin cells <ref>PMID:19537380</ref>. These plaques typically appear on the scalp, knees, elbows and lower back <ref>PMID:19537380</ref>. Remicade has been FDA approved for the treatment of adult patients expressing severe, chronic symptoms <ref>PMID:19537380</ref>. The severity of the disease is ultimately assessed by a physician to determine if Remicade is the right course of action in consideration with other possible therapies <ref>PMID:19537380</ref>.
Plaque psoriasis is the most common form of the disease, appearing as raised, red patches covered with a off-white buildup of dead skin cells<ref>PMID:19537380</ref>. These plaques typically appear on the scalp, knees, elbows and lower back<ref>PMID:19537380</ref>. Remicade has been FDA approved for the treatment of adult patients expressing severe, chronic symptoms<ref>PMID:19537380</ref>. The severity of the disease is ultimately assessed by a physician to determine if Remicade is the right course of action in consideration with other possible therapies<ref>PMID:19537380</ref>.


<b>Psoriatic Arthritis:</b>
<b>Psoriatic Arthritis:</b>